Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Medartis Holding AG is a Switzerland-based holding company overseeing the Medartis Group, a leading global manufacturer of medical devices and implants for surgical fixation and joint replacement of bone fractures in upper and lower extremities, as well as the craniomaxillofacial region. Founded in 1997 and headquartered in Basel, Switzerland, the company develops innovative titanium implants and instruments, emphasizing agility, customer focus, and solutions under its 'From head to toe' vision to help patients regain mobility. Medartis operates 13 locations worldwide, employs around 950 people, and distributes products in over 50 countries, with key growth in EMEA and the US markets. Notable features include advanced systems like TriLock multidirectional locking technology, SpeedTip screws, and recent expansions via acquisitions such as Nextremity Solutions in the US (2022), majority stakes in KeriMedical for hand surgery expertise, and NeoOrtho in Brazil for Latin American trauma and spine implants. In the medical devices sector, Medartis Holding AG plays a significant role in orthopaedics, driving innovation in fracture treatment and joint solutions while enhancing profitability through operational efficiencies.
Operating margin is thin at 0.72%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 19.8%, still solid. Margins contracted 2.5pp, which offsets some of the top-line progress.
Free cash flow declined 55% versus the prior year, cash generation momentum has weakened. Net debt of CHF 125M represents 13.4x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
CHF 269M
▲ +19.8% YoY
Net Income (TTM)
CHF 9M
▲ +164.6% YoY
Op. Margin
0.72%
▼ -2.5pp YoY
ROIC
0.34%
▼ -1.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 9M
▼ -55.5% YoY
Op. Cash Flow (TTM)
CHF 13M
▼ -53.8% YoY
Net Debt
CHF 125M
Cash & Equiv.
CHF 33M
3Y CAGR: +13.8%
Continue Research